Semler Scientific Closes Merger and Delisting with Strive

An announcement from Semler Scientific ( (SMLR) ) is now available.

On January 28, 2025, Semler Scientific completed a $100 million private offering of 4.25% Convertible Senior Notes due 2030, and, following the completion of its merger with Strive, those notes were amended via a supplemental indenture dated January 16, 2026 so that conversions now result in Strive Class A common stock instead of Semler shares, while preserving Semler’s discretion over the form of conversion consideration and cash settlement terms. In connection with the January 16, 2026 merger closing, each outstanding share of Semler common stock was converted into the right to receive 21.05 shares of Strive common stock, all Semler equity awards were rolled into Strive equity on equivalent terms with specified vesting accelerations, the company terminated its at-the-market equity sales agreement, moved to delist and deregister its common stock from Nasdaq and the SEC, and implemented a full change in corporate governance and organizational documents as Merger Sub’s directors, officers, charter and bylaws took effect for the surviving Semler entity, materially reshaping ownership, capital markets access and control for shareholders and noteholders.

The most recent analyst rating on (SMLR) stock is a Hold with a $20.50 price target. To see the full list of analyst forecasts on Semler Scientific stock, see the SMLR Stock Forecast page.

Spark’s Take on SMLR Stock

According to Spark, TipRanks’ AI Analyst, SMLR is a Neutral.

The score is primarily held back by weak operating performance and negative cash flows despite a solid balance sheet. Valuation is a meaningful positive (low P/E), but technicals remain below key longer-term averages and the restructuring/merger-related realignment adds execution risk.

To see Spark’s full report on SMLR stock, click here.

More about Semler Scientific

Semler Scientific, Inc. is a medical technology company that develops and sells diagnostic and health monitoring products, with its primary business centered on providing medical devices and related services to healthcare markets. The company’s securities were previously listed on the Nasdaq Capital Market, giving it access to public equity capital and a broad base of institutional and retail investors.

Average Trading Volume: 664,360

Technical Sentiment Signal: Sell

Current Market Cap: $326.6M

For a thorough assessment of SMLR stock, go to TipRanks’ Stock Analysis page.